293 related articles for article (PubMed ID: 19384176)
1. Rituximab for humoral rejection after kidney transplantation: an update.
Rostaing L; Guilbeau-Frugier C; Kamar N
Transplantation; 2009 Apr; 87(8):1261. PubMed ID: 19384176
[No Abstract] [Full Text] [Related]
2. Single dose of Rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: a case report.
Moscoso-Solorzano GT; Baltar JM; Seco M; López-Larrea C; Mastroianni-Kirsztajn G; Ortega F
Transplant Proc; 2007 Dec; 39(10):3460-2. PubMed ID: 18089407
[TBL] [Abstract][Full Text] [Related]
3. Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection.
Fehr T; Rüsi B; Fischer A; Hopfer H; Wüthrich RP; Gaspert A
Transplantation; 2009 Jun; 87(12):1837-41. PubMed ID: 19543061
[TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
5. Successful therapy with rituximab of refractory acute humoral renal transplant rejection: a case report.
Celik A; Saglam F; Cavdar C; Sifil A; Atila K; Sarioglu S; Bora S; Gulay H; Camsari T
Transplant Proc; 2008; 40(1):302-4. PubMed ID: 18261611
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute humoral rejection in kidney transplantation with plasmapheresis.
Grandtnerová B; Javorský P; Kolácný J; Hovoricová B; Dĕdic P; Laca L
Transplant Proc; 1995 Feb; 27(1):934-5. PubMed ID: 7879238
[No Abstract] [Full Text] [Related]
7. ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab.
Chikaraishi T; Sasaki H; Tsutsumi H; Miyano S; Nakazawa R; Nakano T; Kitajima K; Kudo H; Takahashi T; Sato Y; Kimura K
Transplant Proc; 2008 Dec; 40(10):3445-7. PubMed ID: 19100409
[TBL] [Abstract][Full Text] [Related]
8. Single-dose rituximab as induction in renal transplantation.
van den Hoogen MW; Hilbrands LB
Transplantation; 2010 May; 89(10):1295; author reply 1295. PubMed ID: 20555227
[No Abstract] [Full Text] [Related]
9. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.
Thaunat O; Patey N; Gautreau C; Lechaton S; Fremeaux-Bacchi V; Dieu-Nosjean MC; Cassuto-Viguier E; Legendre C; Delahousse M; Lang P; Michel JB; Nicoletti A
Transplantation; 2008 Jun; 85(11):1648-53. PubMed ID: 18551073
[TBL] [Abstract][Full Text] [Related]
10. Current approaches to treatment of antibody-mediated rejection.
Jordan SC; Vo AA; Tyan D; Nast CC; Toyoda M
Pediatr Transplant; 2005 Jun; 9(3):408-15. PubMed ID: 15910400
[TBL] [Abstract][Full Text] [Related]
11. New treatments for acute humoral rejection of kidney allografts.
Venetz JP; Pascual M
Expert Opin Investig Drugs; 2007 May; 16(5):625-33. PubMed ID: 17461736
[TBL] [Abstract][Full Text] [Related]
12. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.
Ibernón M; Gil-Vernet S; Carrera M; Serón D; Moreso F; Bestard O; Cruzado JM; Grinyó JM
Transplant Proc; 2005 Nov; 37(9):3743-5. PubMed ID: 16386524
[TBL] [Abstract][Full Text] [Related]
13. [Humoral antibody-mediated rejection in kidney transplants].
Teraoka S; Kai K
Nihon Jinzo Gakkai Shi; 2005; 47(5):497-507. PubMed ID: 16130404
[No Abstract] [Full Text] [Related]
14. An interesting case.
Ramírez-González J; Pérez-Garrido J; Rodríguez-Romo R; Uribe-Uribe N; de Leo C; Morales-Buenrostro LE; Alberú J
Clin Transpl; 2006; ():566-9. PubMed ID: 18365437
[No Abstract] [Full Text] [Related]
15. Drug insight: rituximab in renal disease and transplantation.
Salama AD; Pusey CD
Nat Clin Pract Nephrol; 2006 Apr; 2(4):221-30. PubMed ID: 16932428
[TBL] [Abstract][Full Text] [Related]
16. BAFF may modulate the rate of B-cell repopulation after rituximab therapy for acute renal transplant rejection.
Zarkhin V; Li L; Sarwal MM
Transplantation; 2009 Nov; 88(10):1229-30. PubMed ID: 19935379
[No Abstract] [Full Text] [Related]
17. Is a single low-fixed dose of rituximab sufficient for treating acute humoral rejection after kidney transplantation?
Kamar N; Rostaing L
Transplantation; 2009 Jul; 88(1):142; author reply 142-3. PubMed ID: 19584695
[No Abstract] [Full Text] [Related]
18. Transplantation across previously incompatible immunological barriers.
Magee CC
Transpl Int; 2006 Feb; 19(2):87-97. PubMed ID: 16441356
[TBL] [Abstract][Full Text] [Related]
19. Basic mechanisms of humoral rejection.
Cascalho M; Platt JL
Pediatr Transplant; 2005 Feb; 9(1):9-16. PubMed ID: 15667605
[TBL] [Abstract][Full Text] [Related]
20. A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection.
Mulley WR; Hudson FJ; Tait BD; Skene AM; Dowling JP; Kerr PG; Kanellis J
Transplantation; 2009 Jan; 87(2):286-9. PubMed ID: 19155986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
